Clinical Trial Update: International Study for Treatment of High Risk Childhood Relapsed ALL 2010 [Phase 2]

View source ↗

Summary

An international Phase 2 study is investigating treatment for high-risk childhood relapsed acute lymphoblastic leukemia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Status: RECRUITING